View Document Preview and Link Document Date: 2012-12-22 03:08:03 Open Document File Size: 67,54 KB Share Result on Facebook
City San Francisco / Tokyo / / Company Astellas Pharma Inc. / Medivation Inc. / XTANDI Access Services / Mike Beyer Sam Brown Inc / / Country United States / / Event FDA Phase / / IndustryTerm treatment of these diseases / pharmaceutical / food / biopharmaceutical / pharmaceuticals / treatment of metastatic castration-resistant prostate cancer / placebo / / MedicalCondition loss of consciousness / muscular weakness / headache / seizures / cauda equina syndrome / metastatic castration-resistant prostate cancer / diarrhea / prostate cancer / back pain / insomnia / serious diseases / arthralgia / hot flush / hypertension / mouse prostate cancer / hematuria / decreased tumor / upper respiratory infection / seizure / pain / lower respiratory infection / asthenia/fatigue / diseases / spinal cord compression / dizziness / paresthesia / / MedicalTreatment chemotherapy / / Organization Prostate Conditions Education Council / U.S. Food and Drug Administration / / Person Wendy Poage / David Hung / Mark Reisenauer / Jenny Kite / Patrick Machado / / / Position Chief Business & Financial Officer / president / Vice President of Oncology Sales and Marketing / global category leader / co-founder / president and chief executive officer / Director / Investor Relations / / Product XTANDI capsules / prednisone / XTANDI / / ProvinceOrState California / / Technology chemotherapy / / URL www.medivation.com / www.XtandiAccess.com / www.XtandiHCP.com / www.astellas.com/en / / SocialTag 
Medivation Contacts: Patrick Machado Chief Business & Financial Officer[removed]Astellas Contacts: